Company: PRTA
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001559053-25-000023
Chunk: 9

Company: PROTHENA CORP PUBLIC LTD CO
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 9
---
269  
  2028                                                       2,523  
  Thereafter                          —                             
  Total                               $                     11,332  
  Less: Present value adjustment      ( 1,129)                      
  Total lease liability               $                     10,203  
  Less: Lease liability, current      ( 2,628)                      
  Lease liability, non-current        $                      7,575  

Indemnity Obligations

The Company has entered into indemnification agreements with its current and former directors and officers and certain key employees. These agreements contain provisions that may require the Company, among other things, to indemnify such persons against certain liabilities that may arise because of their status or service and advance their expenses incurred as a result of any indemnifiable proceedings brought against them. The obligations of the Company pursuant to the indemnification agreements continue during such time as the indemnified person serves the Company and continues thereafter until such time as a claim can be brought. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a director and officer liability insurance policy that

limits its exposure and enables the Company to recover a portion of any future amounts paid. As a result of its insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. Accordingly, the Company had no liabilities recorded for these agreements as of March 31, 2025, and December 31, 2024.

Other Commitments

In the normal course of business, the Company enters into various firm purchase commitments primarily related to research and development activities. As of March 31, 2025, the Company had non-cancelable purchase commitments to suppliers for $ 15.6 2.2 0.3 10 The following is a summary of the Company's non-cancelable purchase commitments and contractual obligations as of March 31, 2025 (in thousands):

  Purchase Obligations (1)                              $          15,554      $         $         $         $         $     
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                                        Total                  2025      2026      2027      2028      2029  
  Contractual obligations under license agreements      319                    69        70        70        55        55    
  Total                                                 $          15,873      $         $         $         $         $     

________________